Top Pharmaceuticals stocks in Australia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$132.03bn | 33.64 | 1.44% |
NEUNeuren Pharmaceuticals | AU$2.37bn | 15.09 | n/a |
SIGSigma Healthcare | AU$1.99bn | 298.35 | 0.78% |
CUVClinuvel Pharmaceuticals | AU$730.35m | 24.17 | 0.34% |
MYXMayne Pharma | AU$563.03m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$324.90m | n/a | n/a |
PBPProbiotec | AU$230.15m | 25.32 | 2.47% |
RCERecce Pharmaceuticals | AU$136.48m | n/a | n/a |
VLSVita Life Sciences | AU$126.34m | 13.5 | 4.02% |
NXSNext Science | AU$99.18m | n/a | n/a |
PAAPharmaust | AU$89.78m | n/a | n/a |
BIOBiome Australia | AU$68.90m | n/a | n/a |
VITVitura Health | AU$66.23m | 6.98 | 8.7% |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
SPLStarpharma Holdings | AU$55.59m | n/a | n/a |
MVPMedical Developments International | AU$46.60m | n/a | n/a |
LGPLittle Green Pharma | AU$37.51m | n/a | n/a |
IMCImmuron | AU$23.92m | n/a | n/a |
NOXNoxopharm | AU$18.70m | n/a | n/a |
ACRAcrux | AU$17.38m | n/a | n/a |